We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Search Out α-Synuclein Aggregation

Search Out α-Synuclein Aggregation content piece image
Read time: Less than a minute

α-synuclein aggregation is a hallmark characteristic of Parkinson’s disease. Recent studies have revealed that microglia, activated by α-synuclein, can produce cytokines that in turn cause neurons to express MHC I. If these neurons express a specific combination of MHC alleles and peptide, they are targeted for destruction by CD8+ T cells. BioLegend provides reagents to specifically identify antigen-specific T cells with our MHC tetramer technology: Flex-T™. In addition, we offer several phospho- and conformation-specific antibodies for the detection of α-synuclein. 

www.biolegend.com/asynuclein_aggregate_Abs

www.biolegend.com/flex-t